只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-16 2026-07-17 | GLUE Monte Rosa Therapeutics, Inc. | Warmuth Markus Director,Officer · President & CEO | 卖出（S） | 9,500 | US$23.18 | US$220,218.55 | 585,038 | SEC |
| 2026-07-15 2026-07-16 | GLUE Monte Rosa Therapeutics, Inc. | Champoux Jennifer Officer · Chief Operating Officer | 卖出（S） | 4,351 | US$23.38 | US$101,729.86 | 62,371 | SEC |
| 2026-07-06 2026-07-07 | GLUE Monte Rosa Therapeutics, Inc. | Townson Sharon Officer · Chief Scientific Officer | 卖出（S） | 5,600 | US$23.25 | US$130,197.20 | 68,245 | SEC |
| 2026-07-06 2026-07-07 | GLUE Monte Rosa Therapeutics, Inc. | Townson Sharon Officer · Chief Scientific Officer | 卖出（S） | 400 | US$24.13 | US$9,652.00 | 67,845 | SEC |
| 2026-06-30 2026-07-01 | GLUE Monte Rosa Therapeutics, Inc. | Janku Filip Officer · Chief Medical Officer | 卖出（S） | 5,407 | US$24.50 | US$132,471.50 | 60,612 | SEC |
| 2026-06-29 2026-06-30 | GLUE Monte Rosa Therapeutics, Inc. | Manning Anthony M. Director | 卖出（S） | 10,000 | US$23.11 | US$231,100.00 | 0 | SEC |
| 2026-06-29 2026-06-30 | GLUE Monte Rosa Therapeutics, Inc. | Janku Filip Officer · Chief Medical Officer | 卖出（S） | 6,000 | US$22.95 | US$137,700.00 | 59,992 | SEC |
| 2026-06-24 2026-06-25 | GLUE Monte Rosa Therapeutics, Inc. | Janku Filip Officer · Chief Medical Officer | 卖出（S） | 30,000 | US$21.42 | US$642,600.00 | 59,992 | SEC |
| 2026-06-23 2026-06-25 | GLUE Monte Rosa Therapeutics, Inc. | Champoux Jennifer Officer · Chief Operating Officer | 卖出（S） | 2,175 | US$20.00 | US$43,500.00 | 62,371 | SEC |
| 2026-06-23 2026-06-25 | GLUE Monte Rosa Therapeutics, Inc. | Townson Sharon Officer · Chief Scientific Officer | 卖出（S） | 3,000 | US$20.00 | US$60,000.00 | 67,845 | SEC |
| 2026-06-23 2026-06-25 | GLUE Monte Rosa Therapeutics, Inc. | Janku Filip Officer · Chief Medical Officer | 卖出（S） | 11,845 | US$20.22 | US$239,505.90 | 59,992 | SEC |
| 2026-06-17 2026-06-18 | GLUE Monte Rosa Therapeutics, Inc. | Townson Sharon Officer · Chief Scientific Officer | 卖出（S） | 3,000 | US$19.00 | US$57,000.00 | 67,845 | SEC |
| 2026-06-17 2026-06-18 | GLUE Monte Rosa Therapeutics, Inc. | Champoux Jennifer Officer · Chief Operating Officer | 卖出（S） | 2,176 | US$19.00 | US$41,344.00 | 62,371 | SEC |
| 2026-06-01 2026-06-02 | GLUE Monte Rosa Therapeutics, Inc. | Warmuth Markus Director,Officer · President & CEO | 卖出（S） | 4,998 | US$19.41 | US$97,011.18 | 595,006 | SEC |
| 2026-06-01 2026-06-02 | GLUE Monte Rosa Therapeutics, Inc. | Warmuth Markus Director,Officer · President & CEO | 卖出（S） | 468 | US$19.73 | US$9,233.64 | 594,538 | SEC |
| 2026-05-29 2026-06-01 | GLUE Monte Rosa Therapeutics, Inc. | Townson Sharon Officer · Chief Scientific Officer | 卖出（S） | 6,000 | US$19.87 | US$119,220.00 | 67,845 | SEC |
| 2026-05-27 2026-05-28 | GLUE Monte Rosa Therapeutics, Inc. | Champoux Jennifer Officer · Chief Operating Officer | 卖出（S） | 2,175 | US$20.00 | US$43,500.00 | 62,371 | SEC |
| 2026-05-22 2026-05-26 | GLUE Monte Rosa Therapeutics, Inc. | Champoux Jennifer Officer · Chief Operating Officer | 卖出（S） | 2,176 | US$19.00 | US$41,344.00 | 62,371 | SEC |
| 2026-05-21 2026-05-22 | GLUE Monte Rosa Therapeutics, Inc. | Manning Anthony M. Director | 卖出（S） | 10,000 | US$18.01 | US$180,100.00 | 0 | SEC |
| 2026-05-11 2026-05-12 | POR PORTLAND GENERAL ELECTRIC CO /OR/ | HOGLUND ROBERT N Director | 买入（P） | 2,000 | US$48.80 | US$97,600.00 | 2,519 | SEC |
| 2026-05-04 2026-05-05 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 4 | US$74.75 | US$299.00 | 214 | SEC |
| 2026-05-04 2026-05-05 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 4 | US$74.75 | US$299.00 | 198 | SEC |
| 2026-05-04 2026-05-05 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 12 | US$74.75 | US$897.00 | 282 | SEC |
| 2026-05-04 2026-05-05 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 2 | US$74.75 | US$149.50 | 113 | SEC |
| 2026-05-04 2026-05-05 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 2 | US$74.75 | US$149.50 | 113 | SEC |
| 2026-05-04 2026-05-05 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 13 | US$74.75 | US$971.75 | 39 | SEC |
| 2026-05-01 2026-05-05 | GLUE Monte Rosa Therapeutics, Inc. | Warmuth Markus Director,Officer · President & CEO | 卖出（S） | 5,467 | US$18.92 | US$103,435.64 | 600,004 | SEC |
| 2026-05-01 2026-05-04 | CCFN MUNCY COLUMBIA FINANCIAL Corp | Glunk Robert J Director | 买入（P） | 6 | US$74.27 | US$445.62 | 270 | SEC |
| 2026-04-14 2026-04-15 | GLUE Monte Rosa Therapeutics, Inc. | Warmuth Markus Director,Officer · President & CEO | 卖出（S） | 8,000 | US$17.64 | US$141,120.00 | 605,471 | SEC |
| 2026-04-09 2026-04-10 | GLUE Monte Rosa Therapeutics, Inc. | Nickson Philip Officer · Chief Business & Legal Officer | 卖出（S） | 5,845 | US$17.69 | US$103,398.05 | 55,000 | SEC |
| 2026-04-01 2026-04-03 | KTOS KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | HOGLUND WILLIAM A Director | 卖出（S） | 13,103 | US$70.14 | US$919,044.42 | 269,897 | SEC |
| 2026-04-01 2026-04-03 | KTOS KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | HOGLUND WILLIAM A Director | 卖出（S） | 9,062 | US$72.26 | US$654,820.12 | 252,500 | SEC |
| 2026-04-01 2026-04-03 | KTOS KRATOS DEFENSE & SECURITY SOLUTIONS, INC. | HOGLUND WILLIAM A Director | 卖出（S） | 8,335 | US$71.68 | US$597,452.80 | 261,562 | SEC |
| 2026-03-30 2026-04-01 | NONE Lafayette Square USA, Inc. | Tahiroglu Seren Officer · Chief Financial Officer | 买入（P） | 169.15 | US$14.78 | US$2,500.04 | 3,927.18 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| GLUE | 1,375,375.0928 | 53,929.4 | 3,998,371.7816 | 34.40% | B, Q, N |
| GLU | 512.1308 | 0 | 5,715.3475 | 8.96% | Q |